Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.

Als-Nielsen B, Gluud LL, Gluud C.

BMJ. 2004 May 1;328(7447):1046. Epub 2004 Mar 30. Review.

PMID:
15054035
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Nonabsorbable disaccharides for hepatic encephalopathy.

Als-Nielsen B, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2004;(2):CD003044. Review.

PMID:
15106187
[PubMed - indexed for MEDLINE]
3.

Probiotics for patients with hepatic encephalopathy.

McGee RG, Bakens A, Wiley K, Riordan SM, Webster AC.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD008716. doi: 10.1002/14651858.CD008716.pub2. Review.

PMID:
22071855
[PubMed - indexed for MEDLINE]
4.

Disaccharides in the treatment of hepatic encephalopathy.

Sharma P, Sharma BC.

Metab Brain Dis. 2013 Jun;28(2):313-20. doi: 10.1007/s11011-013-9392-4. Epub 2013 Mar 2. Review.

PMID:
23456517
[PubMed - indexed for MEDLINE]
5.

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, Aagaard NK, Vilstrup H.

Metab Brain Dis. 2013 Jun;28(2):221-5. doi: 10.1007/s11011-012-9372-0. Epub 2012 Dec 29. Review.

PMID:
23275147
[PubMed - indexed for MEDLINE]
6.

Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.

Cammà C, Fiorello F, Tinè F, Marchesini G, Fabbri A, Pagliaro L.

Dig Dis Sci. 1993 May;38(5):916-22.

PMID:
8482191
[PubMed - indexed for MEDLINE]
7.

Rifaximin for the treatment of hepatic encephalopathy.

Lawrence KR, Klee JA.

Pharmacotherapy. 2008 Aug;28(8):1019-32. doi: 10.1592/phco.28.8.1019. Review.

PMID:
18657018
[PubMed - indexed for MEDLINE]
8.

Pharmacotherapy for hepatic encephalopathy.

Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A.

Drugs. 2010 Jun 18;70(9):1131-48. doi: 10.2165/10898630-000000000-00000. Review.

PMID:
20518580
[PubMed - indexed for MEDLINE]
9.

Benzodiazepine receptor antagonists for hepatic encephalopathy.

Als-Nielsen B, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2004;(2):CD002798. Review.

PMID:
15106178
[PubMed - indexed for MEDLINE]
10.

Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.

Luo M, Li L, Lu CZ, Cao WK.

Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1250-7. doi: 10.1097/MEG.0b013e32834d1938.

PMID:
21971378
[PubMed - indexed for MEDLINE]
11.

Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.

Jiang Q, Jiang XH, Zheng MH, Jiang LM, Chen YP, Wang L.

Eur J Gastroenterol Hepatol. 2008 Nov;20(11):1064-70. doi: 10.1097/MEG.0b013e328302f470. Review.

PMID:
19047837
[PubMed - indexed for MEDLINE]
12.

Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.

Morgan MY, Alonso M, Stanger LC.

J Hepatol. 1989 Mar;8(2):208-17.

PMID:
2654285
[PubMed - indexed for MEDLINE]
13.

[Hepatic encephalopathy and liver transplantation].

Fehérvári I, Nemes B, Görög D, Gerlei Z, Kóbori L.

Magy Seb. 2012 Apr;65(2):58-62. doi: 10.1556/MaSeb.65.2012.2.4. Review. Hungarian.

PMID:
22512880
[PubMed - indexed for MEDLINE]
14.

The treatment of hepatic encephalopathy.

Morgan MY, Blei A, Grüngreiff K, Jalan R, Kircheis G, Marchesini G, Riggio O, Weissenborn K.

Metab Brain Dis. 2007 Dec;22(3-4):389-405. Review.

PMID:
17846875
[PubMed - indexed for MEDLINE]
15.

Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.

Als-Nielsen B, Kjaergard LL, Gluud C.

Cochrane Database Syst Rev. 2001;(4):CD002798. Review. Update in: Cochrane Database Syst Rev. 2004;(2):CD002798.

PMID:
11687160
[PubMed - indexed for MEDLINE]
16.

First and second generation non absorbable disaccharides in the treatment of hepatic encephalopathy.

Capocaccia L, Riggio O, Merli M.

Ital J Gastroenterol. 1990 Dec;22(6):365-7. No abstract available.

PMID:
2131958
[PubMed - indexed for MEDLINE]
17.

Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.

Patil DH, Westaby D, Mahida YR, Palmer KR, Rees R, Clark ML, Dawson AM, Silk DB.

Gut. 1987 Mar;28(3):255-9.

PMID:
3570029
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis.

Blanc P, Daures JP, Rouillon JM, Peray P, Pierrugues R, Larrey D, Gremy F, Michel H.

Hepatology. 1992 Feb;15(2):222-8.

PMID:
1531204
[PubMed - indexed for MEDLINE]
19.

Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.

Morgan MY, Hawley KE.

Hepatology. 1987 Nov-Dec;7(6):1278-84.

PMID:
3315932
[PubMed - indexed for MEDLINE]
20.

Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.

Heredia D, Caballería J, Arroyo V, Ravelli G, Rodés J.

J Hepatol. 1987 Jun;4(3):293-8.

PMID:
3598162
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk